For instance, in a study using a rat model of MI, VEGF-loaded PLGA nanoparticles were shown to significantly enhance angiogenesis and reduce infarct size compared to free VEGF administration, leading to improved cardiac function[1]. This evidence concerns the gene VEGFA and myocardial infarction.